Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
21.3M
-
Shares change
-
+1.47M
-
Total reported value, excl. options
-
$94.7M
-
Value change
-
+$5.86M
-
Number of buys
-
35
-
Number of sells
-
-45
-
Price
-
$4.44
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q4 2014
98 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q4 2014.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.3M shares
of 52.3M outstanding shares and own 40.8% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2.68M shares), DIMENSIONAL FUND ADVISORS LP (1.89M shares), BlackRock Institutional Trust Company, N.A. (1.47M shares), First Light Asset Management, LLC (1.21M shares), VANGUARD GROUP INC (1.11M shares), BlackRock Fund Advisors (987K shares), RENAISSANCE TECHNOLOGIES LLC (944K shares), Clearbridge Investments, LLC (944K shares), Allianz Asset Management AG (903K shares), and MILLENNIUM MANAGEMENT LLC (884K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.